Home Blog Page 3
Fastly Inc. (FSLY) shares surged nearly 45% from July 24 through Aug 5. -- going from $78 to a high of $117.79. But since then, FSLY has pulled all the way back to $79.25. Tons of volatility, but Fastly's #1 holder -- Abdiel Capital -- hasn't sold a share of its 9.5M share position. Abdiel's Fastly Inc....
If you figure out exactly what Michael Burry was up to in the second quarter of 2020, please let me know. Scion's Q2 13F portfolio released today shows that Burry dumped his #1 holding -- and new position -- from last quarter, Jack in the Box (JACK). His fund Scion Asset Management also liquidated the losing...
Value Investor Clifford Sosin, founder and manager of CAS Investment Partners, runs a concentrated portfolio -- as of Q2's close the fund held only five positions. However, an equal-weighted portfolio of those five stocks is up 80% Year-to-date. The fund's top holding, online car retailer Carvana (CVNA), is up 110% YTD. Sosin recently increased stakes in two...
Activist hedge fund Glenview Capital filed a 13D on Bausch Health (BHC) after market hours Monday. The $13.3B fund, managed by Larry Robbins, disclosed a 5.9% stake in the pharmaceutical company. Bausch Health is now Glenview's #3 portfolio position. BHC shares closed at $18.79 on Tuesday, up 4.39%. BHC is a...
On Friday afternoon, CASI Pharma CEO He Wei-Wu filed a Form 4 disclosing the purchase of nearly $7.9M of CASI stock. The insider bought the shares in a public offering of 20M CASI shares at $1.90. President Larry Zhang also bought 20,153 shares in the secondary offering, his first as a CASI insider. Rockville,...
The Securities and Exchange Commission has proposed significantly raising the size threshold of funds required to file quarterly 13F disclosures. The SEC 13F rule change would end quarterly portfolio filings for nearly 90% of current filers. The proposal would raise the AUM threshold that investment managers must meet every quarter from $100 million...
Two Bed Bath & Beyond insiders bought shares as the slumping retailer published an investor update describing improving June sales trends. After announcing dismal Q1 Covid-19-impacted earnings on July 8, Bed Bath & Beyond (BBBY) management received lots of questions from investors. So on Tuesday, the company released a list of "Frequently Asked Questions." In the Q&A,...
The ten most underrated hedge funds are not famous. But the managers running these funds have consistently generated exceptional returns despite (or maybe because) they fly under the radar. The stock picks of the managers on this list have handily outperformed most of the "wizards of finance" Wall Street gushes over. Investors seeking...
Below is a list of the top ten most overrated hedge fund managers. Many of these guys (they're all men) have become celebrities, idolized by investors, just like movie stars or great athletes are in mainstream American society. And most of them made their billions -- and forged their reputations -- years ago. Recent performance doesn't rise...
On June 17, EcoR1 Capital filed a 13G on Xencor Inc. (XNCR), disclosing the purchase of over 2M shares. EcoR1 now owns 8% of Xencor. The purchase makes XNCR the #1 position in EcoR1's $957M 13F portfolio. Xencor is a clinical-stage biopharmaceutical company developing therapies for the treatment of cancer and autoimmune diseases....